Efficacy and Safety of Low-dose Decitabine in Refractory Aplastic Anemia

NCT04854889 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

3

Enrollment

OTHER

Sponsor class

Stopped Not achieve the desired effect

Conditions

Refractory Aplastic Anemia

Interventions

DRUG: Decitabine

Sponsor

Institute of Hematology & Blood Diseases Hospital, China